跳至主要内容
临床试验/CTRI/2018/11/016266
CTRI/2018/11/016266已完成未知

A Study comparing nebulised Amphotericin B with oral itraconazole for treatment of complex aspergilloma patients attending a tertiary care hospital

Intramural project of AIIMS New Delhi0 个研究点目标入组 32 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients having pulmonary aspergilloma on Computed tomography thorax with symptoms like cough, hemoptysis etc.
  • 2)Age more than 18 years
  • 3)Patients not having other concomitant respiratory infections

排除标准

  • 1)Patients having severe constitutional features like high grade fever, massive hemoptysis etc.
  • 2)Patients who have hypersensitivity to either azoles or Amphotericin B.
  • 3)Patients not giving consent for bronchoscopic intervention or receiving nebulised Amphotericin B
  • 4)overt immunosuppressive state (patients on immunosuppressive drugs, intake of prednisolone (or equivalent) >10 mg for at least 3 weeks, uncontrolled diabetes mellitus and others),
  • 5)Invasive aspergillosis, ABPA, CNPA, active pulmonary tuberculosis or malignancy
  • 6) Pregnancy
  • 7)Patient who are not anti-fungal naïve (who has received antifungals through oral or iv route for more than 7 days in the last 6 months)

研究者

发起方
Intramural project of AIIMS New Delhi

相似试验